Cath Lab Digest talks with Dr. Barry Bertolet about the clinical and economic benefits to reducing Contrast Induced Acute Kidney Injury in the Cath Lab. Dr. Bertolet shares their experience establishing Kidney Care practices for the lab, implementing the DyeVert System, tips for getting started, and the positive outcomes they have observed.
- Assessing the Contrast Induced Acute Kidney Injury rate in your Cath Lab and the need for Quality Improvement.
- Define a starting point to implement Kidney Care in the Cath Lab including simple processes and new technologies like the DyeVert System
- Who would be involved in a multi-disciplinary team to support implementation efforts?
BARRY D. BERTOLET, MD, FACEP, FACC
Cardiology Associates of North Mississippi
Staff Cardiologist; Director, Cardiac Catheterization Laboratory;
Director, Chest Pain Evaluation Unit
North Mississippi Medical Center
Dr. Bertolet is an Interventional Cardiologist with Cardiology Associates of North Mississippi, and Director of the Cardiac Catheterization Laboratories at North Mississippi Medical Center in Tupelo, MS. He performed his undergraduate and medical school work at the University of Mississippi. Dr. Bertolet then went to the University of Florida – Gainesville for internal medicine and cardiology training. He then served on the teaching staff for 5 years before moving to Tupelo. He is board-certified in Internal Medicine, Cardiology, and Interventional Cardiology. Dr. Bertolet is actively involved in research, and has over 50 scientific publications on his CV.
Dr. Bertolet has been selected as Teacher of the Year at the University of Florida-Gainesville as well as North Mississippi Medical Center. He has been selected as one of the “Best Doctors in America”, and voted as a Mississippi HealthCare Hero in 2011.
Dr Bertolet is the Vice President of the Mississippi Health Care Alliance, and was actively involved in the design and development of the state-wide STEMI system of care.